Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00328211 · ClinicalTrials.gov registry record · NA
Intralumenal Effects on Cholesterol Absorption/Synthesis
A NA study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT00328211 is a NA study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 35 participants.
The verdict
NCT00328211, a NA study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The overall goal of this study is to better understand how cholesterol is absorbed and utilized in the body(metabolism) and how serum cholesterol affects the development of hardening of the arteries (atherosclerosis). The purpose of aim 1 is to assess the role of the amount of different bile acids in the intestine and how they affect the absorption, synthesis and digestion of cholesterol. The effect that these bile acids have on how fast the gall bladder empties and the release of a hormone in the blood after a meal will also be studied. The purpose of aim 2 is to assess the role of phospholipid (a fat containing the element phosphorus) in the intestine and how it affects the absorption, synthesis and digestion of cholesterol in normal people and in people with a genetic condition (mdr3 deficiency)that affects phospholipid and bile acid metabolism. The purpose of aim 3 is to assess the role of a material that acts like a detergent called Pluronic F-68 which is known to block the absorption of cholesterol. The purpose of aim 4 is to determine if the cholesterol from food and the cholesterol made by the body are digested and absorbed differently.
Interventions
- DIETARY_SUPPLEMENT Bile Acids (Cholic, Ursodeoxycholic, Chenodeoxycholic)
- DIETARY_SUPPLEMENT Sphingomyelin
- OTHER C13 Stable isotope of Cholesterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2005-09 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00328211
The ClinicalTrials.gov registry entry for NCT00328211 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Bile Acids (Cholic, Ursodeoxycholic, Chenodeoxycholic) is the first listed.
NCT00328211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00328211 about?
NCT00328211 is a clinical study titled "Intralumenal Effects on Cholesterol Absorption/Synthesis". The overall goal of this study is to better understand how cholesterol is absorbed and utilized in the body(metabolism) and how serum cholesterol affects the development of hardening of the arteries (atherosclerosis). The purpose of aim 1 is to assess the role of the amount of different bile acids i...
What is the current status of trial NCT00328211?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2005-09. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00328211?
The interventions under investigation include: Bile Acids (Cholic, Ursodeoxycholic, Chenodeoxycholic) (DIETARY_SUPPLEMENT), Sphingomyelin (DIETARY_SUPPLEMENT), C13 Stable isotope of Cholesterol (OTHER).
Who is sponsoring clinical trial NCT00328211?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.